Rates of postoperative complications among human immunodeficiency virus-infected women who have undergone obstetric and gynecologic surgical procedures

被引:35
作者
Grubert, TA
Reindell, D
Kästner, R
Belohradsky, BH
Gürtler, L
Stauber, M
Dathe, O
机构
[1] Univ Munich, Frauenklin 1, Dept Gynecol & Obstet, D-80337 Munich, Germany
[2] Univ Munich, Dept Pediat, D-80337 Munich, Germany
[3] Univ Munich, Max Von Pettenkofer Inst Hyg & Med Microbiol, D-80337 Munich, Germany
关键词
D O I
10.1086/339043
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Clinical observations indicate that human immunodeficiency virus (HIV)-positive women experience more postoperative problems than do HIV-negative women. To obtain a better estimate of the individual risk of postoperative morbidity among HIV-infected women, and to determine which procedures pose the greatest risk, we performed a retrospective case-control study in which we assessed the outcomes after 235 obstetric and gynecologic surgical procedures. For purposes of comparison, an HIV-negative control patient was matched for each of the 235 surgical procedures performed, on the basis of the type of procedure and patient age. We found a significantly greater number of postoperative complications among the HIV-positive women. Higher complication rates occurred after abdominal surgery (odds ratio [OR], 3.6; P=.001) and curettage (OR, 7.7; P = .06). Among HIV-infected women, the risk of complications was associated with immune status. Anti-retroviral therapy and standard perioperative antibiotic prophylaxis did not decrease the risk of complications. Indications for performing abdominal surgery and curettage on HIV-infected women should be carefully weighed against the potential risk of postoperative complications.
引用
收藏
页码:822 / 830
页数:9
相关论文
共 18 条
[1]  
American College of Obstetricians and Gynecologist, 1999, INT J GYNECOL OBSTET, V66, P305
[2]   The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1 -: A meta-analysis of 15 prospective cohort studies [J].
Andiman, W ;
Boucher, M ;
Burns, D ;
Bryson, Y ;
Farley, J ;
Fowler, H ;
Gabiano, C ;
Galli, L ;
Hutto, C ;
Kind, C ;
Korber, B ;
Kovacs, A ;
Krogstad, P ;
Landesman, S ;
Lapointe, N ;
Lemay, M ;
Lew, J ;
Mandelbrot, L ;
Mayaux, MJ ;
Mellins, R ;
Minkoff, H ;
Mofenson, L ;
Nielsen, K ;
Newell, ML ;
Pardi, G ;
Peavy, H ;
Peckham, C ;
Read, J ;
Rother, C ;
Rudin, C ;
Scott, G ;
Semprini, A ;
Shearer, W ;
Simonds, R ;
Simpson, B ;
Stek, A ;
Tovo, PA ;
Tuomala, R ;
Van Dyke, R ;
Weedon, J ;
de Martino, M ;
Lindsay, M ;
Belair, S ;
Chan, L ;
Harris, D ;
Kalish, L ;
Muenz, L ;
Nugent, R ;
Schluchter, M ;
Durako, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (13) :977-987
[3]   Restoration of the immune system with anti-retroviral therapy [J].
Autran, B ;
Carcelaint, G ;
Li, TS ;
Gorochov, G ;
Blanc, C ;
Renaud, M ;
Durali, M ;
Mathez, D ;
Calvez, V ;
Leibowitch, J ;
Katlama, C ;
Debré, P .
IMMUNOLOGY LETTERS, 1999, 66 (1-3) :207-211
[4]  
Brockmeyer N, 1999, Eur J Med Res, V4, P35
[5]  
Bulterys M, 1996, AIDS, V10, P923, DOI 10.1097/00002030-199607000-00019
[6]  
*CDCP, 2001, HIV AIDS SURV REP AT
[7]  
[Anonymous], 1992, MMWR Recomm Rep, V41, P1
[8]  
EMPARAN C, 1995, EUR J SURG, V161, P721
[9]   Complications after caesarean section in HIV-1-infected women not taking antiretroviral treatment [J].
Grubert, TA ;
Reindell, D ;
Kästner, R ;
Lutz-Friedrich, R ;
Belohradsky, BH ;
Dathe, O .
LANCET, 1999, 354 (9190) :1612-1613
[10]  
Imami N, 1999, CLIN EXP IMMUNOL, V118, P78